Go Dropless

Go Dropless is a branded set of compounded ophthalmic formulations and a practice-branded regimen intended to enable “dropless” cataract surgery by delivering antibiotics and anti‑inflammatory drugs intraoperatively instead of via postoperative topical drops. It is associated with Imprimis’ compounded multi‑drug products that combine a fourth‑generation fluoroquinolone antibiotic with an anti‑inflammatory agent for injection into the eye at the time of cataract surgery, aiming to prevent postoperative endophthalmitis, macular edema, and inflammation while improving adherence and lowering the burden and cost of self‑administered drops.[15][16] The Go Dropless concept is part of broader dropless cataract protocols that use intraocular or periocular steroid and antibiotic delivery in lieu of traditional extended topical regimens.[3][5]

Brand names

Go Dropless